JANE STREET GROUP, LLC - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 315 filers reported holding EDITAS MEDICINE INC in Q4 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q3 2023$538,083
-75.7%
68,985
-74.4%
0.00%
-100.0%
Q2 2023$2,215,022
+167.4%
269,140
+135.5%
0.00%
Q1 2023$828,450
-12.9%
114,269
+6.6%
0.00%
Q4 2022$950,917
-36.6%
107,206
-12.4%
0.00%
-100.0%
Q3 2022$1,499,000
-1.8%
122,450
-5.0%
0.00%0.0%
Q2 2022$1,526,000
-75.3%
128,955
-60.3%
0.00%
-50.0%
Q1 2022$6,174,000
-59.2%
324,576
-43.1%
0.00%
-60.0%
Q4 2021$15,150,000
-62.7%
570,658
-42.3%
0.01%
-64.3%
Q3 2021$40,628,000
-37.0%
988,999
-13.1%
0.01%
-44.0%
Q2 2021$64,483,000
+84.2%
1,138,463
+36.6%
0.02%
+47.1%
Q1 2021$35,008,000
-39.4%
833,526
+1.2%
0.02%
-41.4%
Q4 2020$57,738,000
+467.7%
823,522
+127.2%
0.03%
+383.3%
Q3 2020$10,170,000
-33.4%
362,400
-29.8%
0.01%
-50.0%
Q2 2020$15,272,000
+3191.4%
516,307
+2106.4%
0.01%
Q1 2020$464,000
-88.4%
23,400
-82.7%
0.00%
-100.0%
Q4 2019$4,007,000
+198.1%
135,344
+146.1%
0.01%
+200.0%
Q1 2019$1,344,000
+45.6%
54,990
+35.6%
0.00%0.0%
Q4 2018$923,000
-59.8%
40,550
-43.8%
0.00%
-60.0%
Q3 2018$2,294,000
+872.0%
72,100
+992.4%
0.01%
+400.0%
Q2 2018$236,000
-86.7%
6,600
-87.7%
0.00%
-80.0%
Q1 2018$1,781,000
+101.7%
53,717
+46.1%
0.01%
+150.0%
Q3 2017$883,00036,7710.00%
Other shareholders
EDITAS MEDICINE INC shareholders Q4 2020
NameSharesValueWeighting ↓
Deep Track Capital, LP 7,101,935$55,395,0932.14%
Green Alpha Advisors, LLC 77,188$602,0660.46%
Woodline Partners LP 3,259,710$25,425,7380.30%
TANG CAPITAL MANAGEMENT LLC 200,000$1,560,0000.22%
Spectrum Planning & Advisory Services Inc. 14,038$109,4960.17%
PDT Partners, LLC 156,515$1,220,8170.15%
CALTON & ASSOCIATES, INC. 13,420$104,6760.15%
Corton Capital Inc. 29,365$229,0470.12%
CAXTON ASSOCIATES LP 61,223$477,5390.07%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 119,287$930,4390.06%
View complete list of EDITAS MEDICINE INC shareholders